Results 1 to 10 of about 192,291 (353)
Risk stratification scores for major bleeding in patients with venous thromboembolism
Spanish Journal of Medicine, 2021 The standard treatment for venous thromboembolism (VTE) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient’s preferences.
Francisco Galeano-Valle +2 more
doaj +1 more source
TH Open, 2021 Introduction Dose adjustment based on laboratory monitoring is not routinely recommended for patients treated with rivaroxaban but because an association has been reported between high drug level and bleeding, it would be of interest to know if measuring
Krishnan Shyamkumar +5 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2023 We present an extremely rare case of a patient with intermediate-high risk pulmonary embolism treated with percutaneous mechanical thrombectomy, complicated with stroke as a form of paradoxical embolism through a previously unknown patent foramen ovale ...
Marina López-Rubio +7 more
doaj +1 more source
Renal Vein Thrombosis in Idiopathic Thrombocytopenic Purpura [PDF]
Journal of Clinical and Diagnostic Research, 2020 Renal Vein Thrombosis (RVT) is thrombotic occlusion of one or both main renal veins, resulting in acute or chronic kidney disease. The clinical presentation of RVT depends on the degree of venous occlusion.
Subodh Kumar Das +4 more
doaj +1 more source
Case Reports, 2007 A 50-year-old man presented with flu-like symptoms, breathlessness and palpitations. He was in atrial fibrillation on admission and a subsequent transthoracic echocardiogram revealed severe left ventricular impairment. A working diagnosis of viral cardiomyopathy was made and he was commenced on anticoagulation, an angiotensin converting enzyme ...
Jiun Tuan, Gershan Davis, Farhad Kaivani
openaire +5 more sources
A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension [PDF]
, 2021 Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by recurrent or unresolved pulmonary thromboemboli, leading to perfusion defects and increased arterial wave reflections. CTEPH treatment aims to reduce pulmonary arterial pressure and reestablish adequate lung perfusion, yet patients with distal lesions are inoperable by standard surgical
arxiv +1 more source
A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy
Frontiers in Oncology, 2021 Purpose: The aims of this study were to develop and validate a novel nomogram to predict thromboembolism (TE) in gastric cancer (GC) patients receiving chemotherapy and to test its predictive ability.Methods: This retrospective study included 544 GC ...
Hai-Liang Yuan +9 more
doaj +1 more source
Influence of shear rate and surface chemistry on thrombus formation in micro-crevice [PDF]
Journal of Biomechanics, Volume 121, 2021, 110397, ISSN 0021-9290, 2020 Thromboembolic complications remain a central issue in management of patients on mechanical circulatory support. Despite the best practices employed in design and manufacturing of modern ventricular assist devices, complexity and modular nature of these systems often introduces internal steps and crevices in the flow path which can serve as nidus for ...
arxiv +1 more source
Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study [PDF]
, 2005 Combined oral contraceptives,oral hormone replacement therapy and thrombophilias are recognised risk factors for venous thromboembolism in women.The objective of this study was to assess the risk of thromboembolism among women with thrombophilia who are ...
Brenkel, I. +10 more
core +1 more source